The goal of the research protocol, which was carried out by specialists in neuropharmacology, neurochemistry, and neuroscience, was to show how CBD’s interaction with specific neuroreceptors, such as GPR55, can have positive effects on health in the central nervous system.
“In our model, we studied the effect of CBD administered to mice that were in a parkinsonian state. CBD administration clearly improved motor performance during the administration of the trial,” said Daniel Limón and Dr.
To ensure the most scientifically reliable, valid, and trustworthy results, HempMeds® provided its flagship RSHO-X 5,000 to aid in the study’s execution.
Named one of the top CBD producers by CNBC, Medical Marijuana Inc.’s flagship product, Real Scientific Hemp Oil, has been used in several other successful clinical studies throughout
“Our commitment is to provide free access to non-psychoactive cannabis and its benefits,” said
FORWARD-LOOKING DISCLAIMER:
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements, by definition, involve risks, uncertainties, and other factors that may cause
These statements have not been evaluated by the
LEGAL DISCLOSURE:
CONTACT:
Public Relations Contact:
CMW Media
P. 858-221-8001
mjna@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com
Source:
2022 GlobeNewswire, Inc., source
Be the first to comment